A Villers

Summary

Country: France

Publications

  1. doi request reprint [The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association]
    M Peyromaure
    Service d Urologie, Hopital Cochin, Paris, France
    Prog Urol 20:17-23. 2010
  2. doi request reprint Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance
    Arnauld Villers
    Department of Urology, Centre Hospitalier Regional Universitaire de Lille, Lille, France
    Curr Opin Urol 19:274-82. 2009
  3. pmc Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib
    Alessandra Fiorio Pla
    Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Via Nizza 52, 10126 Torino, Italy
    BMC Cancer 14:939. 2014
  4. doi request reprint MRI in addition to or as a substitute for prostate biopsy: the clinician's point of view
    A Villers
    Service d Urologie, Universite Lille Nord de France, Hopital Huriez, 2, Avenue Oscar Lambret, 59037 Lille, France
    Diagn Interv Imaging 93:262-7. 2012
  5. pmc A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France
    Amine Benchikh
    Hopital Bichat Claude Bernard, Paris, France
    BMC Cancer 10:635. 2010
  6. ncbi request reprint [Biopsy technique and biopsy schemes for a first series of prostatic biopsies]
    Arnauld Villers
    Service d Urologie, Hopital Claude Huriez, Lille, France
    Prog Urol 14:144-53. 2004
  7. doi request reprint [Inhibitors of the receptor A for endothelin-1]
    A Villers
    Service d Urologie, Hopital Huriez, CHRU Lille, 1 place de Verdun Lille cedex, France
    Prog Urol 20:S77-9. 2010
  8. ncbi request reprint ERSPC: features and preliminary results of France
    A Villers
    Department of Urology of Lille, Hopital Huriez, France
    BJU Int 92:27-9. 2003
  9. ncbi request reprint [Management of locally advanced prostatic adenocarcinoma in France. OCTAVE observational survey]
    Arnauld Villers
    Service d Urologie, CHRU Lille, France
    Prog Urol 16:316-9. 2006
  10. ncbi request reprint [Free PSA: its routine use is premature in the screening of prostatic cancer]
    A Villers
    Service d Urologie, Hopital de Rangueil, Toulouse, France
    Prog Urol 10:618-21. 2000

Detail Information

Publications75

  1. doi request reprint [The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association]
    M Peyromaure
    Service d Urologie, Hopital Cochin, Paris, France
    Prog Urol 20:17-23. 2010
    ..To analyze the impact of screening on prostate cancer (PCa) mortality, and to discuss the main points of controversy regarding this screening...
  2. doi request reprint Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance
    Arnauld Villers
    Department of Urology, Centre Hospitalier Regional Universitaire de Lille, Lille, France
    Curr Opin Urol 19:274-82. 2009
    ..To review the current status of MRI techniques in identification of organ-confined prostate cancer with a focus on their implication for focal therapy and active surveillance...
  3. pmc Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib
    Alessandra Fiorio Pla
    Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Via Nizza 52, 10126 Torino, Italy
    BMC Cancer 14:939. 2014
    ..Whether this could depend on differential responses between tumor and normal endothelial cells has not been tested...
  4. doi request reprint MRI in addition to or as a substitute for prostate biopsy: the clinician's point of view
    A Villers
    Service d Urologie, Universite Lille Nord de France, Hopital Huriez, 2, Avenue Oscar Lambret, 59037 Lille, France
    Diagn Interv Imaging 93:262-7. 2012
    ..It could also reduce the number of biopsies to be performed even when the mp-MRI is suspicious, by resorting solely to targeted biopsies. This review does not evaluate the role of mp-MRI in locoregional staging...
  5. pmc A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France
    Amine Benchikh
    Hopital Bichat Claude Bernard, Paris, France
    BMC Cancer 10:635. 2010
    ..Here we investigate the properties of our panel in men subject to clinical work-up before biopsy...
  6. ncbi request reprint [Biopsy technique and biopsy schemes for a first series of prostatic biopsies]
    Arnauld Villers
    Service d Urologie, Hopital Claude Huriez, Lille, France
    Prog Urol 14:144-53. 2004
    ..prostate cancer, particularly concerning prevention of complications, the number of biopsies and the biopsy schemes ensuring an optimal cancer detection rate, and recording of prognostic elements, all with an acceptable morbidity,..
  7. doi request reprint [Inhibitors of the receptor A for endothelin-1]
    A Villers
    Service d Urologie, Hopital Huriez, CHRU Lille, 1 place de Verdun Lille cedex, France
    Prog Urol 20:S77-9. 2010
    ..Inhibitors of receptors of ET-1 in clinical development are the atrasentan and ZD4054. This article reports on controlled, randomized, phase II and III studies on this new therapeutic class...
  8. ncbi request reprint ERSPC: features and preliminary results of France
    A Villers
    Department of Urology of Lille, Hopital Huriez, France
    BJU Int 92:27-9. 2003
  9. ncbi request reprint [Management of locally advanced prostatic adenocarcinoma in France. OCTAVE observational survey]
    Arnauld Villers
    Service d Urologie, CHRU Lille, France
    Prog Urol 16:316-9. 2006
    ..To describe the management of patients with locally advanced prostate cancer in France and the changes in this management between 2000 and 2003...
  10. ncbi request reprint [Free PSA: its routine use is premature in the screening of prostatic cancer]
    A Villers
    Service d Urologie, Hopital de Rangueil, Toulouse, France
    Prog Urol 10:618-21. 2000
    ..Total PSA assay (cut-off value: 4 ng/ml) remains the reference laboratory test for screening and indication of biopsies. A lower normal cut-off value (between 2 and 4 ng/ml) is currently under evaluation...
  11. ncbi request reprint Modified extrafascial radical retropubic prostatectomy technique decreases frequency of positive surgical margins in T2 cancers <2 cm(3)
    A Villers
    Department of Urology, Centre Hospitalier Universitaire Purpan, Toulouse, France
    Eur Urol 38:64-73. 2000
    ..In an effort to decrease the frequency of postoperative positive surgical margins (+SM), a modified extrafascial radical prostatectomy technique was developed and evaluated...
  12. ncbi request reprint [Indication and strategy for further biopsies following the diagnosis of prostatic intra-epithelial neoplasia]
    A Villers
    Service d Urologie, Hopital Claude Huriez, Lille, France
    Prog Urol 10:1267-70. 2000
    ..In the case of a first series of non-systematized biopsies, a new series of systematized biopsies is recommended...
  13. doi request reprint [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm]
    F Boulière
    Service d Urologie, CHU de Rennes, Universite Rennes 1, 2, rue Henri Le Guilloux, 35033, Rennes, France
    Prog Urol 21:842-50. 2011
    ..The objective of the present study was to analyse whether nephron-sparing surgery (NSS) was superior to radical nephrectomy (RN) in preserving renal function outcome in tumors larger than 4cm...
  14. ncbi request reprint [Variations of the practice of radical prostatectomy in France]
    M Soulie
    INSERM U518, Laboratoire d épidémiologie et de santé publique, Toulouse, France
    Prog Urol 11:49-55. 2001
    ..The objective of this study was to analyse RP practice in France, and its determinants and geographical variations based on the CCAFU-Francim survey on prostate cancer (PC) diagnosed in 1995...
  15. ncbi request reprint Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: a multi-institutional study
    B Malavaud
    Department of Urology, Centre Hospitalo Universitaire Purpan, Toulouse, France
    Eur Urol 37:281-8. 2000
    ....
  16. doi request reprint [Oncologic outcomes after radical prostatectomy: French validation of the D'Amico risk group classification]
    A Ouzzane
    Service d Urologie, CHU Lille, Universite Lille Nord de France, 59000 Lille, France
    Prog Urol 20:1206-12. 2010
    ..To validate the D'Amico risk group classification in French consecutive series and to analyse recurrence risk factor after radical prostatectomy (RP) for prostate cancer...
  17. doi request reprint Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model
    G Bozzini
    Lille University Hospital, Department of Urology, France
    Photodiagnosis Photodyn Ther 10:296-303. 2013
    ..To evaluate photodynamic therapy (PDT) using 5-ALA-induced protoporphyrin IX (PPIX) in an in vivo hypoxic tumor model and its monitoring using MRI...
  18. doi request reprint Focal therapy of prostate cancer: energies and procedures
    G Bozzini
    Department of Urology, Centre Hospitalier Regional Universitaire de Lille, Lille, France
    Urol Oncol 31:155-67. 2013
    ..Different energy modalities are being developed. The aim of this study is to review these energy modalities and their indications...
  19. doi request reprint Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract using diffusion-weighted MRI
    A Sufana Iancu
    Department of Nephro urological Radiology, Claude Huriez Hospital, CHRU Lille, Universite Lille Nord de France, 1, Rue Michel Polonovski, 59037, Lille, France
    World J Urol 31:13-9. 2013
    ..To evaluate utility of diffusion-weighted magnetic resonance imaging (DWI) to detect and predict the histological characteristics of upper urinary tract urothelial carcinomas (UTUCs)...
  20. doi request reprint [PSA and follow-up after treatment of prostate cancer]
    A Benchikh El Fegoun
    Service d Urologie, Hopital Claude Huriez, 2, Avenue Oscar Lambret, 59037 Lille Cedex, France
    Prog Urol 18:137-44. 2008
    ..However, when PSADT greater than six months, the risk of metastasis is less than 3% even for PSA greater than 30 ng/ml. When PSADT less than six months and PSA greater than 10 ng/ml, the risk of metastasis is close to 50%...
  21. doi request reprint [Recommendations for best practice for prostate biopsy]
    A Ouzzane
    Service d Urologie, Universite Lille Nord de France, CHU de Lille, 59000 Lille, France
    Prog Urol 21:18-28. 2011
    ..the aim of these recommendations is to help urologists to optimize prostate biopsy practice in order to improve diagnosis yield and to minimize associated morbidity...
  22. ncbi request reprint [Secondary biological recurrence after radical prostatectomy: multivariate analysis of prognostic clinical, biological, and histologic factors]
    B Malavaud
    Service de Chirurgie Urologique et de Transplantation Rénale, Hopital Rangueil, Toulouse, France
    Prog Urol 11:277-82. 2001
    ..To define the clinical, laboratory and histological variables associated with secondary elevation, after an undetectable phase, of PSA after radical prostatectomy...
  23. doi request reprint [Renal cell carcinoma of patients younger than 40 years old]
    T P Ghoneim
    Service d Urologie, Université de Lille Nord de France, Hopital Claude Huriez, CHU de Lille, 2, Rue Michel Polonovski, 59000 Lille, France
    Prog Urol 22:93-9. 2012
    ..The objective of this study was to analyze these characteristics by comparison to a group of patients aged 58 to 62...
  24. ncbi request reprint [Cancer of the prostate in France: results of the survey CCAFU-FRANCIM]
    M Soulie
    INSERM U518, Laboratoire d épidémiologie et de santé publique, Toulouse, France
    Prog Urol 11:478-85. 2001
    ..The objective of this survey was to analyse the diagnostic and therapeutic modalities of prostate cancer in 1995, on the basis of a population derived from 4 French cancer registries...
  25. doi request reprint [Prognostic significance of lymphovascular invasion in upper urinary tract carcinoma: a retrospective monocentric analysis]
    P Colin
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, Universite Lille Nord de France, Rue Michel Polonovski, 59037 Lille Cedex, France pierre
    Prog Urol 22:331-8. 2010
    ..To analyze the prognostic impact of lymphovascular invasion (LVI) in case of urothelial carcinoma of upper urinary tract (UUT-UC)...
  26. doi request reprint [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004]
    V Flamand
    Service d Urologie, Hopital Huriez, CHRU de Lille, 59037 Lille Cedex, France
    Prog Urol 18:53-9. 2008
    ..The aim of this work is to study variations of prostate cancer incidence by stage as a function of time and place in a region of France...
  27. doi request reprint [Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage]
    J Rizk
    Service d Urologie, CHRU Lille, Universite Lille Nord de France, 59000 Lille, France Electronic address
    Prog Urol 25:157-68. 2015
    ..To assess long term biochemical recurrence free survival after radical prostatectomy according to open, laparoscopic and robot-assisted surgical approach and clinicopathological stage...
  28. doi request reprint Photodynamic therapy in urology: what can we do now and where are we heading?
    G Bozzini
    Department of Urology, Centre Hospitalier Regional Universitaire de Lille, Avenue Oscar Lambret, Lille, France bozzini
    Photodiagnosis Photodyn Ther 9:261-73. 2012
    ..The aim of this study is to review applications of this technique in urology...
  29. doi request reprint [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy]
    M Peyromaure
    Service d Urologie, Hopital Necker, 149, rue de Sevres, 75015 Paris, France
    Prog Urol 18:2-8. 2008
    ..To assess the time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy...
  30. ncbi request reprint Medical and non-medical determinants of prostate cancer management: a population-based study
    E Bauvin
    Réseau Français des Registres de Cancer, Faculté de Médecine de Purpan, 31073 Cedex, Toulouse, France
    Eur J Cancer 39:2364-71. 2003
    ..This type of investigation, if carried out regularly, would make it possible to evaluate changes in practice patterns...
  31. ncbi request reprint [Transrectal ultrasound and biopsy of the prostate]
    L Lemaitre
    Service de Radiologie et d Imagerie Médicale, Hopital Claude Huriez, 59037 Lille Cedex
    J Radiol 87:201-9. 2006
    ....
  32. doi request reprint [Factors influencing the choice of nondonor families in a French organ-harvesting center]
    F Hénon
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, 1, Place de Verdun, 59037 Lille Cedex, France Electronic address
    Prog Urol 26:656-661. 2016
    ..Report the reasons that lead families to refuse organ donation during their close solicitation by hospital coordination...
  33. doi request reprint [How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]
    P Bigot
    UMR 60 61 CNRS, Service d Urologie, CHU de Rennes, Universite Rennes 1, 2 rue Henri Le Guilloux, Rennes, France
    Prog Urol 20:350-5. 2010
    ..Our objective was to compare oncologic results of nephron sparing surgery (NSS) versus radical nephrectomy (RN) in T1aN0-x M0 papillary renal cell carcinoma (PRCC)...
  34. doi request reprint [Renal extramedullary hematopoiesis]
    A Broucqsault
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, Rue Michel Polonovski, 59000 Lille, France
    Prog Urol 21:575-9. 2011
    ..Systemic therapies using iron supplementation or blood transfusion are helpful to avoid disease recurrence. We report a case of pyelocaliceal EMH managed with laser vaporization during ureteroscopy procedures...
  35. doi request reprint [Strategies in castration-resistant prostate cancer]
    T Bessede
    Service d Urologie, Hopital Bicetre, 78, rue du General Leclerc, 94275 Le Kremlin Bicetre cedex, France
    Prog Urol 21:S68-71. 2011
    ..Endothelin inhibitors, abiraterone, MDV3100 or RD162 are the most promising examples but they require to enroll patients in therapeutic trials...
  36. pmc Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)
    A Villers
    CHRU Hôpital Huriez, Lille, France
    Br J Cancer 89:S50-8. 2003
  37. doi request reprint [Testicular nodules of infertile men and contrast enhanced ultrasonography: preliminary study]
    P Vandaele
    Service d Urologie, Hopital Huriez, CHRU de Lille, 1, Place de Verdun, 59037 Lille, France Electronic address
    Prog Urol 25:274-81. 2015
    ..These nodules are suspicious of malignancy. There is no paraclinical examination which allows histological orientation to these nodules. The recommendations propose priority treatment by total orchidectomy...
  38. ncbi request reprint [Prostatic biopsies: technical modalities and conditions of the test]
    V Ravery
    Service d Urologie, Hopital Bichat, Paris, France
    Prog Urol 10:1271-6. 2000
    ..The technical modalities and examination conditions of prostate biopsies were evaluated in the light of a review of the literature and the conclusions are presented in the form of standards, options and recommendations...
  39. doi request reprint [Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility]
    P Colin
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, Lille Cedex, France pierre
    Prog Urol 20:1-10. 2010
    ..To date, there is a growing body of evidence supporting that the interaction between individual genetic susceptibilities and environmental toxic exposure is a key to explain carcinogenesis in the majority of sporadic UUT UCC occurrence...
  40. ncbi request reprint Prostate cancer characterization on MR images using fractal features
    R Lopes
    INSERM, U703, Université Nord de France, 152 rue du Docteur Yersin, 59120 Loos, CHRU Lille, France
    Med Phys 38:83-95. 2011
    ..Computerized detection of prostate cancer on T2-weighted MR images...
  41. ncbi request reprint [Klippel-Trenaunay syndrome and multiple vesical hemangiomas: treatment with Neodymium:YAG laser]
    L Zini
    Service d Urologie, CHRU de Lille, France
    Prog Urol 11:1282-4. 2001
    ..Its most frequent clinical manifestation is haematuria. The diagnosis is based on endoscopy. Endoscopic treatment by Neodymium:YAG (Nd:YAG) laser photocoagulation appears to be a satisfactory treatment option...
  42. doi request reprint [Lynch syndrome and risk of prostate cancer; review of the literature]
    F Maillard
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, 1, Place de Verdun, 59037 Lille Cedex, France Electronic address
    Prog Urol 25:225-32. 2015
    ..The association between Lynch syndrome and prostate cancer has been studied. Recent studies report an association between these two diseases...
  43. doi request reprint [Evolution of the number of incident cases of prostate cancer in France from 2001 to 2012 from 5 hospital centers]
    O Helfrich
    Service d Urologie, Universite Lille Nord de France, CHU de Lille, 59000 Lille, France
    Prog Urol 25:147-56. 2015
    ..The secondary objective is to describe the characteristics of the incident cases and to compare them to those of the patients of the national registers of cancer for the period...
  44. doi request reprint [Family refusal of organ donation: a retrospective study in a French organ procurement center]
    J Le Nobin
    Service d Urologie, Hopital Claude Huriez, CHRU de Lille, 1, Place de Verdun, 59037 Lille Cedex, France Electronic address
    Prog Urol 24:282-7. 2014
    ..In France, organ donation refusal rates approach 32% of eligible brain deaths. Outright family refusal represents the primary barrier reason for declining organ donation. This retrospective study evaluated factors influencing this decision...
  45. ncbi request reprint Tumour necrosis in chromophobe renal cell carcinoma: clinical data to distinguish aggressive variants
    L Zini
    Department of Urology, Huriez Hospital, Lille, France
    Eur J Surg Oncol 34:687-91. 2008
    ..To assess correlation between necrosis on imaging and pathology reports and prognostic value of tumour necrosis in chromophobe renal cell carcinoma (CRCC)...
  46. ncbi request reprint [Difficult clinical cases in prostate cancer: multidisciplinary staff, the rational principles of adjuvant therapy and other therapeutic options]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:S35-41. 2006
    ..Immediate hormonal therapy with bicalutamide is a valuable therapeutic option in men having prostate cancer with such clinicopathological features...
  47. doi request reprint High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology
    Xavier Rebillard
    Clinique Beau Soleil, Montpellier, France
    BJU Int 101:1205-13. 2008
    ..The median-term survival data also seem promising, but long-term follow-up studies are needed to further evaluate cancer-specific and overall survival rates before the indications for primary therapy can be expanded...
  48. ncbi request reprint Endoluminal occlusion of the inferior vena cava in renal cell carcinoma with retro- or suprahepatic caval thrombus
    Laurent Zini
    Department of Urology, Lille Regional University Teaching Hospital CHRU, Lille, France
    BJU Int 97:1216-20. 2006
    ..To evaluate endoluminal occlusion of the inferior vena cava (IVC) during surgical treatment of renal cell carcinoma (RCC) with either retrohepatic (level II) or suprahepatic (level III) caval tumour thrombus...
  49. ncbi request reprint [Should scrotal ultrasound be discouraged in cases of suspected spermatic cord torsion?]
    Laurent Zini
    Clinique d Urologie, Hopital Huriez, 59037 Lille
    Prog Urol 13:440-4. 2003
    ..To assess the value of scrotal ultrasound to guide the diagnosis of torsion of the spermatic cord...
  50. ncbi request reprint [Place of contrast imaging in prostate cancer detection]
    François Cornud
    Service de Radiologie, Paris, France
    Prog Urol 16:275-80. 2006
    ..However, this technique cannot yet be recommended in routine practice, as the modalities of injection of the latest generation of microbubbles (bolus or infusion) need to be evaluated...
  51. ncbi request reprint Renal cell carcinoma associated with tumor thrombus in the inferior vena cava: surgical strategies
    Laurent Zini
    Service d Urologie, Lille, France
    Ann Vasc Surg 19:522-8. 2005
    ..In patients with level III thrombus, TEE-guided endoluminal occlusion of the unobstructed infradiaphragmatic IVC simplifies surgical management by obviating the need for exposure of the retrohepatic and supradiaphragmatic IVC...
  52. ncbi request reprint Seasonality of serum prostate-specific antigen levels: a population-based study
    Gilles Salama
    Laboratoire de Biologie, Centre Hospitalier Général Castres Mazamet, France
    Eur Urol 52:708-14. 2007
    ..To assert the relationship between total and free PSA and meteorological data in 8644 participants (55-70 years) in the French arm of the ERSPC study...
  53. ncbi request reprint [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder]
    Patrick Bourguet
    Centre Eugene Marquis, Rennes
    Bull Cancer 93:1228-32. 2006
  54. ncbi request reprint [The prostate: how to treat this symbol of male vulnerability? An Association Française d'Urologie (AFU)-IPSOS qualitative survey]
    Bardon Yves
    Prog Urol 17:199-202. 2007
    ..As part of a second phase, this article presents the results of a complementary study conducted among general practitioners to identify their expectations and the most appropriate levers to promote screening...
  55. ncbi request reprint [The epidemiology of prostate cancer]
    Xavier Rebillard
    Service d Urologie, Clinique Beau Soleil, 34000 Montpellier
    Rev Prat 53:2224-8. 2003
    ..Hereditary risk factors permit a definition of a target population for screening. Environmental factors are little known, but a diet rich in fat seems to be associated with a more elevated risk...
  56. ncbi request reprint [Update on screening, diagnosis and treatment of cancer of the prostate]
    Bruno Chauvet
    Institut Sainte Catherine, BP 846, 84082 Avignon cedex 2
    Bull Cancer 89:37-45. 2002
    ..For hormonoresistant metastatic disease, chemotherapy has been used with limited palliative benefit. New drugs are currently evaluated...
  57. ncbi request reprint Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance
    Laurent Zini
    Department of Urology, Lille University Hospital, Lille, Cedex, France
    J Urol 179:450-4; discussion 454. 2008
    ..We also determined whether it is a prognostic factor for recurrence and survival after radical nephrectomy and thrombus ablation for renal cell carcinoma with an inferior vena cava tumor thrombus...
  58. ncbi request reprint [Primary neuroectodermal tumour of the kidney invading the wall of the inferior vena cava. Surgical strategy]
    Laurent Zini
    Service d Urologie, CHRU Lille, France
    Prog Urol 14:544-7. 2004
    ..They describe the surgical management of this tumour and present a review of the literature...
  59. ncbi request reprint [Prostatic cancer]
    Michel Soulie
    Prog Urol 14:913, 915-55. 2004
  60. ncbi request reprint [Prostate cancer screening]
    Arnauld Villers
    Prog Urol 13:209-14. 2003
    ..Information concerning the limits, benefits and risks of screening and the available treatment options must be given before performing these examinations...
  61. ncbi request reprint MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma
    Xavier Leroy
    Department of Pathology, Faculty of Medicine, Center Hospitalier Régional et Universitaire, 59045 Lille, France
    Am J Surg Pathol 27:519-21. 2003
    ..In contrast, all seminal vesicles were diffusely immunostained with MUC6 antibody. We concluded that MUC6 is a valuable marker of seminal vesicle-ejaculatory duct and is useful for the differential diagnosis with prostate adenocarcinoma...
  62. ncbi request reprint Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings
    Arnauld Villers
    Department of Urology, Hospital Claude Huriez, Centre Hospitalier Regional Universitaire de Lille, 59037 Lille, France
    J Urol 176:2432-7. 2006
    ..We assessed the value of pelvic phased array dynamic contrast enhanced magnetic resonance imaging for predicting the intraprostatic location and volume of clinically localized prostate cancers...
  63. ncbi request reprint [CAT Scan in hormone-independent prostate cancer]
    Frederic Staerman
    Prog Urol 12:37-43. 2002
  64. ncbi request reprint [Long-term oncological results after conservative surgery for unifocal renal cancer]
    Cyril Gerard
    Service d Urologie, Hopital Claude Huriez, 2, avenue O Lambret, 59035 Lille
    Prog Urol 13:14-22. 2003
    ..To evaluate the risk of local recurrence and metastatic spread of renal cancer treated by conservative surgery with a minimum follow-up of 5 years...
  65. ncbi request reprint [Cost and efficacy of treatment strategies in localized prostatic cancer: feasibility study in the general population]
    Eric Bauvin
    INSERM U558, Faculté de Médecine de Purpan, Toulouse, France
    Prog Urol 13:618-23. 2003
    ..Medico-economic studies are necessary to evaluate healthcare practices. The objective of this preliminary study is to show how this type of study can be conducted in the general population based on cancer registries...
  66. ncbi request reprint Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53
    Xavier Leroy
    Centre Hospitalier Universitaire de Lille, Department of Pathology, Parc Eurasante, Lille, nord 59037 France
    Arch Pathol Lab Med 131:102-6. 2007
    ..Adult renal cell carcinoma (RCC) with rhabdoid features is a recently recognized morphologic variant of kidney carcinoma. To date, only very few studies have been published on this subject and p53 was not previously studied...
  67. ncbi request reprint [Prostate cancer screening]
    Michel Soulie
    Prog Urol 13:1272-5. 2003
  68. ncbi request reprint [Molecular forms of PSA]
    Amine Benchikh El Fegoun
    Service d Urologie, CHRU Lille, France
    Prog Urol 17:165-71. 2007
    ..Preliminary studies did not have demonstrate their ability to discriminate between cancer and BPH, and did not define cutoff values...
  69. ncbi request reprint Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI
    Philippe Puech
    INSERM, U703 of Lille, France
    Conf Proc IEEE Eng Med Biol Soc 2007:5567-70. 2007
    ..ProCAD is a computer assisted diagnosis (CAD) software dedicated to prostate DCE-MRI analysis...
  70. ncbi request reprint [Prostatic cancers]
    Michel Soulie
    Prog Urol 17:1159-230. 2007
  71. ncbi request reprint [Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature]
    Jérémie Haffner
    Service d Urologie, Centre Oscar Lambret, Lille
    Prog Urol 17:1305-9. 2007
    ..Gastric or duodenal metastases from clear cell renal cell carcinoma are exceptional. According to autopsy series, the incidence of gastrointestinal metastases is 0.06 to 4% for all cancers and 0.2 and 0.7% for renal cancers...
  72. ncbi request reprint [Cystic prostate cancer: a clinical entity of ductal carcinoma]
    Laurent Zini
    Service d Urologie, CHRU Lille
    Prog Urol 14:411-3. 2004
    ..The cystic appearance of the peripheral prostatic zone appears to be a distinct clinical and morphological entity of ductal carcinomas. This entity has never been previously reported...
  73. ncbi request reprint [Indications for pelvic lymphadenectomy in clinically localized prostate cancer]
    Michel Peneau
    Service d Urologie, CHR Orleans La Source, France
    Prog Urol 14:287-94. 2004
    ..Frozen section examination of lymph nodes during total prostatectomy is also controversial due to its low sensitivity (66%). The objective of this article is to define the indications for lymphadenectomy and frozen section examination...
  74. ncbi request reprint [Surgery of prostate cancer]
    Arnauld Villers
    Service d Urologie, Hopital Huriez, CHRU, 59037 Lille
    Rev Prat 53:2246-52. 2003
    ..Laparoscopic approach was described mainly by French teams since 1997 and represents a validated alternative to the gold standard suprapubic open approach...
  75. ncbi request reprint [Prostate cancer]
    Arnauld Villers
    Service d Urologie, Centre Hospitalier Regional et Universitaire, Hopital Claude Huriez, 59037 Lille Cedex
    Rev Prat 56:1021-5. 2006